General Information of Drug (ID: DMZLFVG)

Drug Name
Pyrrolopyrimidine Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
577022
TTD Drug ID
DMZLFVG

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulfinpyrazone DMEV954 Gout FA25 Approved [2]
Benzbromarone DMC3YUA Gout FA25 Approved [3]
XR-9456 DMTUFI1 Discovery agent N.A. Investigative [4]
XR-9504 DMIQP69 Discovery agent N.A. Investigative [4]
XR-9544 DM1OZPN Discovery agent N.A. Investigative [4]
XR-9577 DMIZV6T Discovery agent N.A. Investigative [4]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Multidrug resistance-associated protein 1 (ABCC1) TTOI92F MRP1_HUMAN Inhibitor [1]

References

1 Topological model for the prediction of MRP1 inhibitory activity of pyrrolopyrimidines and templates derived from pyrrolopyrimidine. Bioorg Med Chem Lett. 2005 Nov 15;15(22):4967-72.
2 Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2). Drug Metab Dispos. 2008 Apr;36(4):631-40.
3 Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transpo... Drug Metab Dispos. 2009 Jan;37(1):129-36.
4 Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors. Bioorg Med Chem. 2008 Mar 1;16(5):2448-62.